Expand ANIX Menu
ANIX MENU

ANIX Latest Press Releases

-- August 24, 2026 --

Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy PRNewswire 8:55 AM

-- August 18, 2026 --

Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference PRNewswire 8:45 AM

-- July 6, 2026 --

Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date PRNewswire 8:30 AM

-- June 29, 2026 --

Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040 PRNewswire 8:46 AM

-- June 26, 2026 --

Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium PRNewswire 9:11 AM

-- June 11, 2026 --

Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium PRNewswire 9:05 AM

-- June 1, 2026 --

Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance PRNewswire 9:08 AM

-- May 11, 2026 --

/C O R R E C T I O N -- Anixa Biosciences, Inc./ PRNewswire 11:49 AM
Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy PRNewswire 8:55 AM

-- May 1, 2026 --

Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV PRNewswire 9:15 AM

-- April 29, 2026 --

Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology PRNewswire 9:10 AM

-- April 22, 2026 --

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting PRNewswire 8:45 AM

-- April 9, 2026 --

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 PRNewswire 9:05 AM

-- April 7, 2026 --

Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 PRNewswire 8:55 AM

-- April 6, 2026 --

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs PRNewswire 9:10 AM

-- April 1, 2026 --

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing PRNewswire 8:50 AM

-- March 30, 2026 --

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer PRNewswire 9:05 AM
Market Data Delayed 15 Minutes